DK93091D0 - Laegemidler til behandling af toxoplasmose - Google Patents

Laegemidler til behandling af toxoplasmose

Info

Publication number
DK93091D0
DK93091D0 DK91930A DK93091A DK93091D0 DK 93091 D0 DK93091 D0 DK 93091D0 DK 91930 A DK91930 A DK 91930A DK 93091 A DK93091 A DK 93091A DK 93091 D0 DK93091 D0 DK 93091D0
Authority
DK
Denmark
Prior art keywords
treatment
toxoplasmosis
prophylaxis
animal
toxoplasmose
Prior art date
Application number
DK91930A
Other languages
English (en)
Other versions
DK93091A (da
DK175716B1 (da
Inventor
Alan Thomas Hudson
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK93091D0 publication Critical patent/DK93091D0/da
Publication of DK93091A publication Critical patent/DK93091A/da
Application granted granted Critical
Publication of DK175716B1 publication Critical patent/DK175716B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK199100930A 1989-09-22 1991-05-16 Anvendelse af en substitueret naphthoquinon eller et derivat deraf til fremstilling af et lægemiddel til behandling af toxoplasmose DK175716B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8921516 1989-09-22
GB898921516A GB8921516D0 (en) 1989-09-22 1989-09-22 Medicaments
PCT/GB1989/001286 WO1991004021A1 (en) 1989-09-22 1989-10-26 Medicaments for the treatment of toxoplasmosis
GB8901286 1989-10-26

Publications (3)

Publication Number Publication Date
DK93091D0 true DK93091D0 (da) 1991-05-16
DK93091A DK93091A (da) 1991-06-28
DK175716B1 DK175716B1 (da) 2005-01-31

Family

ID=10663513

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199100930A DK175716B1 (da) 1989-09-22 1991-05-16 Anvendelse af en substitueret naphthoquinon eller et derivat deraf til fremstilling af et lægemiddel til behandling af toxoplasmose

Country Status (17)

Country Link
EP (1) EP0445141B1 (da)
JP (1) JP2810746B2 (da)
KR (1) KR920700626A (da)
AT (1) ATE108063T1 (da)
AU (1) AU628422B2 (da)
CA (1) CA2001568C (da)
DE (1) DE68916651T2 (da)
DK (1) DK175716B1 (da)
GB (1) GB8921516D0 (da)
HU (1) HU207942B (da)
IE (1) IE66153B1 (da)
MC (1) MC2142A1 (da)
MW (1) MW1291A1 (da)
PH (1) PH27250A (da)
SG (1) SG28346G (da)
WO (1) WO1991004021A1 (da)
ZA (1) ZA898146B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9126874D0 (en) * 1991-12-18 1992-02-19 Wellcome Found Medicaments
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
WO2010023686A2 (en) * 2008-08-29 2010-03-04 Matrix Laboratories Limited Crystalline form of 2-chloro-3-[4-(4-chlorophenyl) cyclohexyl] [1,4]naphthoquinone, process for the same and use for producing 2-[4-(4-chlorophenyl)cyclohexyl]-3- hydroxy- 1,4- naphthoquinone
WO2013093937A2 (en) * 2011-09-16 2013-06-27 Alkem Laboratories Ltd. ''3-(5-methyl-2-oxo-l, 3-dioxol-4-yl) methyloxy-2- trans-[(4-chloro phenyl) cyclohexyl] [1,4]naphthaquinone"-atovaquone prodrug
CN104474416A (zh) * 2014-11-03 2015-04-01 青岛绿曼生物工程有限公司 治疗猪弓形体病的复方蜂胶组合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
DE68928964T2 (de) * 1988-08-16 1999-07-29 Wellcome Found Neue Naphthochinone und ihre Anwendung als Arzneimittel

Also Published As

Publication number Publication date
IE893451A1 (en) 1991-03-27
DK93091A (da) 1991-06-28
HU896916D0 (en) 1991-08-28
DK175716B1 (da) 2005-01-31
CA2001568A1 (en) 1991-03-22
PH27250A (en) 1993-05-04
HU207942B (en) 1993-07-28
EP0445141B1 (en) 1994-07-06
AU628422B2 (en) 1992-09-17
AU4519189A (en) 1991-04-18
HUT57040A (en) 1991-11-28
WO1991004021A1 (en) 1991-04-04
DE68916651T2 (de) 1995-02-16
ZA898146B (en) 1991-06-26
DE68916651D1 (de) 1994-08-11
KR920700626A (ko) 1992-08-10
MW1291A1 (en) 1991-11-13
GB8921516D0 (en) 1989-11-08
CA2001568C (en) 1998-05-12
IE66153B1 (en) 1995-12-13
EP0445141A1 (en) 1991-09-11
MC2142A1 (fr) 1992-02-18
JP2810746B2 (ja) 1998-10-15
SG28346G (en) 1995-09-18
ATE108063T1 (de) 1994-07-15
JPH04504107A (ja) 1992-07-23

Similar Documents

Publication Publication Date Title
DK93091D0 (da) Laegemidler til behandling af toxoplasmose
NO912414L (no) Forbindelse med mavesyreinhiberende effekt og fremgangsmaate for dens fremstilling.
DK50092D0 (da) Praeparat til behandling af cryptosporidiose
ES2105643T3 (es) Uso de la 2-(4-(4-clorofenil)ciclohexil)-3-hidroxi-1,4-naftoquinona para el tratamiento del cancer.
ATE404192T1 (de) Verwendung von nefiracetam zur behandlung von postischemischer neurodegeneration
ES2144452T3 (es) Medicamento para el tratamiento de infecciones protozoarias provocadas por babesia.
RU98101105A (ru) Новое применение в медицинских целях
ATE110714T1 (de) Derivate von hydroxaminsäure die lipoxygenase hemmen.
GEP19970834B (en) 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
DK0505389T3 (da) Antiparasitisk præparat til animalsk anvendelse
BR0016427A (pt) Método para o tratamento e/ou prevenção da tosse em um animal de sangue quente, uso de um composto, composto, e, composição farmacêutica

Legal Events

Date Code Title Description
PUP Patent expired